32 results match your criteria: "Shaare Zedek Hospital[Affiliation]"
Isr J Med Sci
June 1989
Department of Internal Medicine, Shaare Zedek Hospital, Jerusalem, Israel.
J Pediatr
March 1989
Department of Neonatology, Shaare Zedek Hospital, Jerusalem, Israel.
Immunol Invest
July 1989
Pediatric Research Laboratories, Shaare Zedek Hospital, Jerusalem.
We describe here a series of experiments which have been undertaken in the course of several years to try and study secretory mechanisms operative in the release of antibodies in the lumen of the intestine. The results of our experiments suggest that there are a number of stimuli that are efficacious in eliciting antibody release in the lumen of the rat intestine. These include the peptide hormones cholecystokinin and substance P, and cholinergic agonists such as pilocarpine.
View Article and Find Full Text PDFJ Pediatr Gastroenterol Nutr
April 1988
Department of Pediatrics, Shaare Zedek Hospital, Jerusalem, Israel.
Following previous observations that medium chain triglycerides (MCT) are absorbed from the stomach of suckling rats, this study was devoted to studying absorption of MCTs in human infants. Four groups of patients were studied: (a) infants suffering from pyloric stenosis, (b) premature infants, (c) children suffering from cystic fibrosis, (d) infants with miscellaneous conditions. Infant formulae with known amounts of MCT were introduced by gastric tube and samples were removed at 0, 20, 40, and 60 min.
View Article and Find Full Text PDFGastroenterology
December 1987
Department of Pediatrics, Shaare Zedek Hospital, Jerusalem, Israel.
Cholecystokinin has previously been shown to produce a rise in immunoglobulin A (IgA) antibodies in the intestinal fluid of human volunteers. Whether the source of these antibodies was pancreatic, biliary, or mucosal had not been defined. The object of the present investigation was to study factors involved in regulating the release of IgA and IgG antibodies from the intestinal mucosa.
View Article and Find Full Text PDFAdv Exp Med Biol
January 1988
Department of Pediatrics, Shaare Zedek Hospital, Jerusalem.
Neurosci Lett
April 1976
Neurology Unit and Neurobiochemistry Clinical Laboratory, Shaare Zedek Hospital, Jerusalem, Israel.
"In vitro" studies were undertaken to evaluate the fate of DPH in blood of uremic patients. DPH incubated for 18 h at 37 degrees C disappears from plasma in the presence of erythrocytes and more when the blood underwent hemolysis. This phenomenon was more pronounced in uremic blood.
View Article and Find Full Text PDF